NovoNordisk A/S

Known for

Ozempic AU

Rivals analysis in progress

Portfolio

Free 3

apps

Medical1

Last updated

Ozempic AU

Publisher DNA

AI intelligence is not yet available for NovoNordisk A/S. The portfolio data below is up to date.

Top niches they play in

Diabetes Management Companions1 app

Explore the Diabetes Management Companions niche

See every app competing in NovoNordisk A/S's strongest niche.

Go deeper

Portfolio

Apps

3 apps analysed

Sort by

Ozempic AU

View Intel →

Analysis in progress

Ozempic® Suomi

Novo Nordisk

3.6(15)

View Intel →

すくすく成長曲線

View Intel →

Analysis in progress

Single-market publisher — every app ships only to United States.

Based on 1 of 3 apps with localized market data — more coverage rolling in as scans complete · last scanned Jun 2026.

Americas (1)

United States1 / 1

Core markets (1/1 apps)

United States

User sentiment

User-sentiment analysis coming soon.

Rivals

Rival analysis coming soon.

So what?

Strategic outlook coming soon.

Frequently asked questions

How many apps does NovoNordisk A/S publish?

NovoNordisk A/S has 3 apps tracked by Marlvel, primarily in the Medical category.

What kind of apps does NovoNordisk A/S make?

NovoNordisk A/S's portfolio is concentrated in Medical, with an average rating of 3.6/5 across rated apps.

What is NovoNordisk A/S's top app?

Based on user sentiment and following across the portfolio, Ozempic AU stands out as NovoNordisk A/S's flagship app tracked by Marlvel.

In how many countries are NovoNordisk A/S's apps available?

Marlvel has tracked NovoNordisk A/S's apps across 1 country.

Snapshot

Publisher DNA

Top niches they play in

Portfolio

Apps

Americas (1)

Core markets (1/1 apps)

User sentiment

Rivals

So what?

Frequently asked questions